Serplulimab (HLX 10) is a humanized anti-PD-1 monoclonal antibody. Serplulimab can inhibit tumor growth, regulate the tumor microenvironment, and has anti-tumor activity. Serplulimab can be used in the research of cancer such as lung cancer and colon cancer[1][2].
Molecular Weight:
(144.18 kDa)
Purity:
99.30
CAS Number:
[2231029-82-4]
Target:
Akt,PD-1/PD-L1,STAT
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
